Premier-Path-Wealth-Partners

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-04-21
Total Holdings
372
Total Value
642708650
Accession Number
0001999925-25-000002
Form Type
13F-HR
Manager Name
Premier-Path-Wealth-Partners
Data Enrichment
86% identified
320 identified52 unidentified

Holdings

372 positions • $642.7M total value
Manager:
Search and click to pin securities to the top
Page 19 of 19
EXELON CORP
Shares:4.5K
Value:$207.5K
% of Portfolio:0.0% ($207.5K/$642.7M)
MOODYS CORP /DE/
Shares:444
Value:$206.7K
% of Portfolio:0.0% ($206.7K/$642.7M)
Blue Owl Capital Corp
Shares:14.0K
Value:$205.2K
% of Portfolio:0.0% ($205.2K/$642.7M)
Snowflake Inc.
Shares:1.4K
Value:$203.2K
% of Portfolio:0.0% ($203.2K/$642.7M)
FAIR ISAAC CORP
Shares:110
Value:$202.9K
% of Portfolio:0.0% ($202.9K/$642.7M)
MITSUBISHI UFJ FINANCIAL GROUP INC
Shares:11.7K
Value:$159.1K
% of Portfolio:0.0% ($159.1K/$642.7M)
46137V621
Shares:10.2K
Value:$146.3K
% of Portfolio:0.0% ($146.3K/$642.7M)
Calumet, Inc. /DE
Shares:11.5K
Value:$146.2K
% of Portfolio:0.0% ($146.2K/$642.7M)
Arbutus Biopharma Corp
Shares:40.0K
Value:$139.6K
% of Portfolio:0.0% ($139.6K/$642.7M)
Roivant Sciences Ltd.
Shares:12.0K
Value:$121.1K
% of Portfolio:0.0% ($121.1K/$642.7M)
ANAVEX LIFE SCIENCES CORP.
Shares:10.0K
Value:$85.8K
% of Portfolio:0.0% ($85.8K/$642.7M)
Amylyx Pharmaceuticals, Inc.
Shares:20.3K
Value:$71.7K
% of Portfolio:0.0% ($71.7K/$642.7M)